Intravitreal bevacizumab in the treatment of vasoproliferative retinal tumours

AimTo evaluate the efficacy of intravitreal bevacizumab in the treatment of retinal vasoproliferative tumours (VPT).Materials and MethodsSix eyes of 6 patients with VPT who received intravitreal bevacizumab were retrospectively reviewed. All patients received between one and three injections of intravitreal bevacizumab depending upon response to treatment… CONTINUE READING